4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001185945-25-000005
Director sold 1,775 shares at $9.24 ($16,401)
- Director acquired 4,062 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A Director | 2025-10-10 | Option exercise 10b5-1 | +4,062 | $1.23 | $4,996 | 58,854 | D |
| RALLIS CHRIS A Director | 2025-10-10 | Sale 10b5-1 | −1,775 | $9.24 | $16,401 | 57,079 | D |
| Derivatives | |||||||
| RALLIS CHRIS A Director | 2025-10-10 | Option exercise · Common Shares 10b5-1 | −4,062 | $1.23 | $4,996 | 174,344 | D |
| Open-market sales · 1,775 sh · avg $9.24 · $16,401 | |||||||
Loading xslF345X05/form4-10142025_041001.xml…